CXCR3 and central nervous system cancer: Of interest, both in vitro and in vivo experiments using different glioma tumors, including GL261 cells, indicated CXCL9 and CXCL10 (which bind to their endogenous receptor CXCR3) as key ligands promoting the growth of glioma (Liu et al., 2011).